Securing the U.S. Biopharma Innovation System against Bad Ideas
March 7, 2024
By Jeffery Depp and Tisyaketu Sirkar The journey of Katalin Kariko and Drew Weissman’s Nobel prize-winning invention of modified nucleotides—essential components of the mRNA vaccines—to their commercial application in vaccines that aided in arresting the Covid-19 pandemic illustrates the importance of a robust innovation system that is founded